Patient Assistance from the Teva Cares Foundation

Teva Respiratory is committed to providing patients with high-quality medicines. You may qualify for assistance from the Teva Cares Foundation if you meet the conditions below.

To qualify for assistance from this program, patients must:

  • Be a resident of the United States
  • Not be eligible for any prescription drug benefits through any private or public insurer/payer/program
  • Have a total family annual income of 300%—or less—of the federal poverty level
  • Have a prescription for one or more of the Teva medicines listed on the application

To enroll:

  • Download a copy of the Teva Cares Foundation application with instructions to complete and return it to the Teva Cares Foundation
  • Your healthcare provider must complete and return his or her section of the application as well
  • You will be notified by mail of program acceptance or denial
  • Your medicine(s) will be shipped to your home address
  • Once you are approved for the program, you will be eligible to receive assistance for up to 12 months
  • Renewals will be handled on an annual basis
  • If you have any questions, please call the Teva Cares Foundation's toll-free number: 1-877-237-4881

Approved Use

AirDuo RespiClick is a prescription medicine used to treat asthma in patients 12 years and older.

AirDuo RespiClick is not used to relieve sudden breathing problems from asthma and won't replace a rescue inhaler.

Important Safety Information

  • AirDuo RespiClick contains salmeterol. Long-acting beta2-agonist (LABA) medicines such as salmeterol when used alone increase the risk of hospitalizations and death from asthma problems. AirDuo RespiClick contains an inhaled corticosteroid (ICS) and a LABA. When an ICS and a LABA are used together, there is not a significant increased risk in hospitalizations and death from asthma problems.
  • Do not use AirDuo RespiClick to treat sudden breathing problems from asthma. Always have a rescue inhaler with you to treat sudden symptoms.
  • Do not use AirDuo RespiClick if you have a severe allergy to milk proteins or if you are allergic to any of the ingredients in the product. Ask your healthcare provider if you are not sure.
  • Do not use AirDuo RespiClick more often than prescribed.
  • Do not take AirDuo RespiClick with other medicines that contain a LABA for any reason.
  • Tell your healthcare provider about all the medicines you take and about all of your health conditions.
  • AirDuo RespiClick can cause serious side effects, including:
    • fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using AirDuo RespiClick to help reduce your chance of getting thrush.
    • weakened immune system and increased chance of getting infections (immunosuppression). You should avoid exposure to chickenpox and measles, and, if exposed, tell your healthcare provider right away. Worsening of existing tuberculosis, fungal, bacterial, viral, or parasitic infections, or herpes infection of the eye (ocular herpes simplex) may occur.
    • reduced adrenal function. This can happen when you stop taking an oral corticosteroid (such as prednisone) and start taking a medicine containing an inhaled corticosteroid (such as AirDuo RespiClick). During this transition period, when your body is under stress such as from fever, trauma (such as a car accident), infection, or surgery, adrenal insufficiency can get worse and may cause death. Symptoms of adrenal insufficiency include:
      • feeling tired
      • lack of energy
      • weakness
      • nausea andvomiting
      • low blood pressure
  • sudden breathing problems immediately after inhaling your medicine. If you have sudden breathing problems immediately after inhaling your medicine, stop using AirDuo RespiClick and call your healthcare provider right away.
  • serious allergic reactions. Stop using AirDuo RespiClick and call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction:
    • rash
    • hives
    • swelling of your face, mouth, and tongue
    • breathing problems
  • effects on heart
    • increased blood pressure
    • a fast or irregular heartbeat
    • chest pain
  • effects on nervous system
    • tremor
    • nervousness
  • bone thinning or weakness (osteoporosis)
  • slowed growth in children. A child's growth should be checked often.
  • eye problems including glaucoma and cataracts. You should have regular eye exams while using AirDuo RespiClick.
  • changes in laboratory blood values (sugar, potassium, certain types of white blood cells)
  • Common side effects of AirDuo RespiClick include:
    • Infection of nose and throat (nasopharyngitis)
    • thrush in your mouth or throat. Rinse your mouth with water without swallowing after use to help prevent this.
    • back pain
    • back pain
    • headache
    • cough
  • These are not all the possible side effects of AirDuo RespiClick. Call your healthcare provider for medical advice about side effects.
  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The above Important Safety Information and Approved Use apply to both AirDuo RespiClick and its Authorized Generic, Fluticasone Propionate and Salmeterol Inhalation Powder (Multidose Dry Powder Inhaler).

Please see full Prescribing Information, and Patient Information, for AirDuo RespiClick.

Please see full Prescribing Information, and Patient Information, for Fluticasone Propionate and Salmeterol Inhalation Powder (MDPI).

This link will take you to a site that may be maintained by a third party who is solely responsible for its contents.

Teva Respiratory provides this link as a service to website visitors. Teva Respiratory is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?